Cardiff University and Siemens Healthineers have entered a strategic partnership to develop advanced medical technologies, with a focus on MR imaging and in vitro diagnostics.
The alliance builds on a 10-year collaboration between the two, and they will work together on developments in MR hardware, biophysical modeling, and MR acquisition strategies using AI to develop efficient acquisition protocols. These aim to capture intricate "fingerprints" of tissue microstructure in health, developmental processes, aging, and various disease states.
The company and university added that integrating these imaging and biochemical analysis modalities will provide innovative approaches to the diagnosis and treatment of other conditions including cancer and diseases associated with infection and immunity.
The partnership also builds on existing collaborations in the field of clinical laboratory diagnostics, with the university having one onsite scientist from Siemens Healthineers. The Cardiff University Brain Research Imaging Centre is developing a step-change in imaging technology and has leveraged Siemens Healthineers' imaging technology to secure grant income of over 54.5 million pounds.
